[Treatment and prevention of fractures in stroke patients].
Sato
Yoshihiro
Y
Department of Neurology, Mitate Hospital.
D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001842:Bone and Bones / Q000378:metabolism; D002116:Calcitonin / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use*; D005265:Femoral Neck Fractures / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology / Q000378:metabolism; D010024:Osteoporosis / Q000209:etiology / Q000378:metabolism; D020521:Stroke / Q000150:complications* / Q000378:metabolism; D014807:Vitamin D / Q000627:therapeutic use; D014808:Vitamin D Deficiency / Q000209:etiology / Q000378:metabolism; D024482:Vitamin K 2 / Q000031:analogs & derivatives / Q000627:therapeutic use
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D024482:Vitamin K 2; D014807:Vitamin D; C030814:menatetrenone; D002116:Calcitonin